CONMED: Pay

CONMED paid its 4 named executives $12.7M in total in FY2025 (Dec). CEO Patrick J. Beyer was paid $7.6M of that.

PayNo stock prices for these years
CEO pay is from each proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Pay of each named executive

Patrick J. BeyerPresident and Chief Executive Officer
FY2025 (Dec)Not disclosed
FY2024 (Dec)
FY2022 (Dec)Not disclosed
FY2021 (Dec)Not disclosed
4 years
Todd W. Garner –Executive Vice President, Finance and Chief Financial Officer
FY2022 (Dec)Not disclosed
FY2021 (Dec)Not disclosed
2 years
Hollie FoustExecutive Vice President, General Counsel and Corporate Secretary
FY2025 (Dec)
1 year
Brent LalomiaExecutive Vice President, Regulatory Affairs, Quality Assurance, Clinical Affairs, and Commercial Operations
FY2025 (Dec)Not disclosed
1 year
Peter K. ShagoryExecutive Vice President, Strategy and Corporate Development
FY2025 (Dec)Not disclosed
FY2024 (Dec)
2 years

CEO pay against the pay peers

In FY2025 (Dec), the median CEO pay of the 7 peers with pay on file was $6.7M. The CEO of CONMED was paid $7.6M, 13% above the median.

  1. 1Integra Lifesciences Holdings
  2. 2AtriCure
  3. 3CONMED
  4. 4Teleflex
  5. 5Merit Medical Systems
  6. 6Varex Imaging
  7. 7Globus Medical
  8. 8Penumbra
  9. 9Avanos Medical, Inc.Not disclosed
  10. 10EnovisNot disclosed
  11. 11HaemoneticsNot disclosed
  12. 12ICU Medical, Inc.Not disclosed
  13. 13LivaNovaNot disclosed
  14. 14Masimo CorporationNot disclosed

Pay of each named executive comes from the Summary Compensation Table of each proxy statement. Realized pay adds the value of options used and stock that vested. CEO pay of each peer comes from its own Pay versus Performance table.